Saruta T, Okuno T, Eguchi T, Nakamura R, Saito I, Kondo K, Oka M, Matsuki S
Acta Endocrinol (Copenh). 1979 Dec;92(4):702-9. doi: 10.1530/acta.0.0920702.
To elucidate the control mechanism of aldosterone production in primary aldosteronism, in vivo and in vitro studies were done in 7 patients with aldosterone-producing adenomas. In the in vivo study, plasma aldosterone was stimulated more significantly by (Formula: see text), synthetic ACTH than by angiotensin II or furosemide. Diurnal variations of plasma aldosterone, which were studied in 4 patients, were similar to those seen in normal controls. In agreement with the results in the in vivo study, the in vitro study also revealed ACTH stimulated aldosterone and deoxycorticosterone (DOC) from the adenoma more markedly than angiotensin II or III. There was no adenoma which was more sensitivie to angiotenion II or III than to ACTH. From these results it is considered that changes in plasma aldosterone induced by the exogenous administration of angiotensin II or ACTH in patients with aldosterone-producing adenoma are mainly based on changes in aldosterone production in the adenoma. Furthermore, in patients with an aldosterone-producing adenoma in whom diurnal variations of plasma aldosterone similar to those in normal subjects are observed, responses of aldosterone to angiotensin II are supposed to be less than those to ACTH.
为阐明原发性醛固酮增多症中醛固酮产生的控制机制,对7例醛固酮分泌性腺瘤患者进行了体内和体外研究。在体内研究中,合成促肾上腺皮质激素(公式:见正文)比血管紧张素II或速尿更显著地刺激血浆醛固酮。在4例患者中研究的血浆醛固酮的昼夜变化与正常对照者相似。与体内研究结果一致,体外研究还显示促肾上腺皮质激素比血管紧张素II或III更显著地刺激腺瘤分泌醛固酮和脱氧皮质酮(DOC)。没有腺瘤对血管紧张素II或III比促肾上腺皮质激素更敏感。从这些结果可以认为,醛固酮分泌性腺瘤患者外源性给予血管紧张素II或促肾上腺皮质激素引起的血浆醛固酮变化主要基于腺瘤中醛固酮产生的变化。此外,在观察到血浆醛固酮昼夜变化与正常受试者相似的醛固酮分泌性腺瘤患者中,醛固酮对血管紧张素II的反应应该小于对促肾上腺皮质激素的反应。